Document is current
Any future updates will be listed below
-
Authors
Svensson, Jonas E.
Bolin, Martin
Thor, Daniel
Williams, Pete A.
Brautaset, Rune
Carlsson, Marcus
Sörensson, Peder
Marlevi, David
Spin-Neto, Rubens
Probst, Monika
Hagman, Göran
Morén, Anton Forsberg
Kivipelto, Miia
Plavén-Sigray, Pontus
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 28 February 2024
Accepted: 8 March 2024
First Online: 4 April 2024
Declarations
:
: The study protocol and relevant documents were approved following review by the Swedish Medical Products Agency (Läkemedelsverket, number: 5.1-2023-8283), and the Swedish Ethical Review Authority (Etikprövningsmyndigheten, number: 2023-03075-02 and 2023-00611-01), EudraCT number: 2023-000127-36. The trial has been registered at ClinicalTrials.gov (NCT06022068, first released on August 30, 2023). Prior to study enrolment, informed consent will be obtained from each participant and their study partner.
: The authors declare no competing interests.
